Open access
542
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain
C. Moya-Alarcóna Medical Affairs Department, Pfizer SLU, Madrid, SpainView further author information
, J.R. Azanzab Department of Clinical Pharmacology, University of Navarra, Pamplona, SpainView further author information
, J. Barberánc Department of Intensive Medicine, Hospital HM Montepríncipe, Madrid, SpainView further author information
, R. Ferrerd Department of Intensive Medicine, Hospital Universitari Vall d’Hebron, Barcelona, SpainView further author information
, M. Kwone Department of Hematology, Hospital Gral. Univ. Gregorio Marañón, Institute of Health Research Gregorio Marañón, Madrid, SpainView further author information
, A. Morenof Department of Pharmacy, Hospital Universitario Salamanca, Salamanca, SpainView further author information
, C. Rubio-Terrésg Health Value SL, Madrid, SpainCorrespondence[email protected]
View further author information
& View further author information
M. Gálvez-Santistebana Medical Affairs Department, Pfizer SLU, Madrid, SpainView further author information
show all
Received 04 Dec 2023, Accepted 29 Feb 2024, Published online: 18 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.